Clinical trials recruiting for Osteopenia

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Pilot Study of Vitamin K2 (Menaquinone-7, Soloways ™) in Patients With Osteopenia/Osteoporosis Carrying a VDR Gene Variant
  NCT06867952 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 75 Years · Sex: All (male and female) · 1 location
• Clinical Study to Estimate Bone Mineral Density With the POROUS Ultrasound Device
  NCT07187518 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 55 Years · Sex: All (male and female) · 2 locations
• Functional Muscle-Bone Incongruity Index (FKUI): A Prospective Observational Study
  NCT07677033 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Peripheral Mononuclear Cells to Screen, Monitor and Stratify the Population at Risk of Osteoporosis and Fractures
  NCT06551155 · Phase: Not specified · Ages: 40 Years and older · Sex: All (male and female) · 2 locations
• Physical Activity Guarantees Bone Density.
  NCT06606769 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years and older · Sex: Female · 1 location
• REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)
  NCT07412782 · Phase: Not applicable (e.g. observational or device study) · Ages: 5 Years to 18 Years · Sex: All (male and female) · 1 location
• Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women
  NCT07191353 · Phase: Phase 2 · Ages: 60 Years to 75 Years · Sex: Female · 2 locations
• Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
  NCT07083557 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · 2 locations
• The Impact of Hormonal Contraceptive Use and Lifestyle Factors on Fracture Risk and Bone Quality in Young Female Adults
  NCT06608862 · Phase: Not specified · Ages: 18 Years to 35 Years · Sex: Female · 1 location
• Zoledronic Acid for the Prevention of TDF-sparing ART-induced Bone Mass Density Loss in Treatment-naive HIV Positive Individuals
  NCT06762730 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations

Related conditions

Trials recruiting for Osteopenia often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Osteopenia trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.